- Home
- ESTA vs MIST Comparison
ESTA vs MIST Comparison
Compare ESTA & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ESTA | MIST |
|---|---|---|
| Founded | 2004 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Biotechnology: Pharmaceutical Preparations |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 146.9M |
| IPO Year | 2018 | 2019 |
Fundamental Metrics
Financial Performance| Metric | ESTA | MIST |
|---|---|---|
| Price | $63.04 | $0.82 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 9 | 7 |
| Target Price | ★ $102.44 | $5.86 |
| AVG Volume (30 Days) | 260.2K | ★ 1.4M |
| Earning Date | 11-04-2026 | 11-11-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 42.67 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $61,208,000.00 | N/A |
| Revenue This Year | $28.00 | $147.62 |
| Revenue Next Year | $25.55 | $476.43 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 76.49 | N/A |
| 52 Week Low | $38.38 | $0.75 |
| 52 Week High | $97.59 | $3.06 |
Technical Indicators
Market Signals| Indicator | ESTA | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 31.76 | 40.29 |
| Support Level | $53.16 | N/A |
| Resistance Level | $68.27 | $1.42 |
| Average True Range (ATR) | 2.33 | 0.06 |
| MACD | -0.28 | -0.00 |
| Stochastic Oscillator | 15.19 | 46.38 |
Price Performance
Historical ComparisonAbout ESTA Establishment Labs Holdings Inc.
Establishment Labs Holdings Inc is a medical technology company engaged in offering medical devices and aesthetic products. It is involved in the designing, manufacturing, and marketing of silicone-filled breast and body-shaping implants. The company markets its products under Motiva implants Brand. It distributes its products to medical distributors; and physicians, hospitals, and clinics in the form of direct sales. Its geographical segments are Europe, Latin America, Asia-Pacific/Middle East, and Others.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.